- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Patent holdings for IPC class A61K 45/06
Total number of patents in this class: 40020
10-year publication summary
3903
|
4143
|
4171
|
4503
|
4319
|
4538
|
4833
|
4324
|
3658
|
1045
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Novartis AG | 11238 |
568 |
The Regents of the University of California | 18943 |
420 |
Merck Sharp & Dohme LLC | 3689 |
313 |
Bristol-myers Squibb Company | 5080 |
280 |
Board of Regents, The University of Texas System | 5370 |
280 |
Genentech, Inc. | 3742 |
275 |
Dana-Farber Cancer Institute, Inc. | 2455 |
268 |
Boehringer Ingelheim International GmbH | 4629 |
255 |
Gilead Sciences, Inc. | 1879 |
244 |
The Johns Hopkins University | 5377 |
204 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
204 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
194 |
Regeneron Pharmaceuticals, Inc. | 3650 |
184 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
183 |
The General Hospital Corporation | 4517 |
170 |
Emory University | 1498 |
165 |
Immatics Biotechnologies GmbH | 1144 |
162 |
Pfizer Inc. | 3322 |
161 |
Yale University | 2204 |
157 |
Centre National de La Recherche Scientifique | 9632 |
156 |
Other owners | 35177 |